Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Correction

Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1

Hans Neubauer1, Susan E Clare1,2, Wojciech Wozny3, Gerhard P Schwall3, Slobodan Poznanovic3, Werner Stegmann3, Ulrich Vogel4, Karl Sotlar4,5, Diethelm Wallwiener1, Raffael Kurek1,6, Tanja Fehm1 and Michael A Cahill3,7 email

Department of Obstetrics and Gynecology, University of Tuebingen, Calwerstraße, 72076 Tübingen, Germany

Current Address: Department of Surgery, Indiana University School of Medicine, W Walnut Street, Indianapolis, Indiana, 46202, USA

ProteoSys AG, Carl-Zeiss-Straße, 55129 Mainz, Germany

Department of Pathology, University of Tuebingen, Liebermeisterstraße, 72076 Tübingen, Germany

Current Address: Department of Pathology, Ludwig-Maximilians-University of Munich, Thalkirchnerstraße, 80337 Munich, Gemany

Current Address: Merck-Serono – Global Clinical Development Unit Oncology, Merck KGaA, Frankfurter Straße, 64293 Darmstadt, Germany

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia

author email corresponding author email

Breast Cancer Research 2009, 11:401doi:10.1186/bcr2216

Published: 13 January 2009

First paragraph (this article has no abstract)

Following the publication of our article [1] we noticed an error in the abstract, within the paragraph headed 'Results'. The serine residue, serine-181, referred to in this paragraph should be serine-180.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.